The acceptability and clinical impact of using polygenic scores for risk-estimation of common cancers in primary care: a systematic review
Open Access
- 21 May 2024
- journal article
- review article
- Published by Springer Nature in Journal of Community Genetics
- Vol. 15 (3) , 217-234
Abstract
Background: Polygenic scores (PGS) have been developed for cancer risk-estimation and show potential as tools to prompt earlier referral for high-risk individuals and aid risk-stratification within cancer screening programmes. This review explores the potential for using PGS to identify individuals at risk of the most common cancers seen in primary care. Methods: Two electronic databases were searched up until November 2023 to identify quantitative, qualitative, and mixed methods studies that reported on the acceptability and clinical impact of using PGS to identify individuals at highest risk of breast, prostate, colorectal and lung cancer in primary care. The Mixed Methods Appraisal Tool (MMAT) was used to assess the quality of included studies and a narrative synthesis was used to analyse data. Results: A total of 190 papers were identified, 18 of which were eligible for inclusion. A cancer risk-assessment tool incorporating PGS was acceptable to the general practice population and their healthcare providers but major challenges to implementation were identified, including lack of evidence for PGS in non-European ancestry and a need for healthcare provider education in genomic medicine. A PGS cancer risk-assessment had relatively limited impact on psychosocial outcomes and health behaviours. However, for prostate cancer, potential applications for its use in primary care were shown. Conclusions: Cancer risk assessment incorporating PGS in primary care is acceptable to patients and healthcare providers but there is a paucity of research exploring clinical impact. Few studies were identified, and more research is required before clinical implementation of PGS can be recommended.Keywords
This publication has 53 references indexed in Scilit:
- Can Communicating Personalised Disease Risk Promote Healthy Behaviour Change? A Systematic Review of Systematic ReviewsAnnals of Behavioral Medicine, 2017
- Primary care providers’ cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agendaJournal of General Internal Medicine, 2016
- The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysisBMJ, 2016
- Risk prediction tools for cancer in primary careBritish Journal of Cancer, 2015
- Effects of genetic and environmental risk assessment feedback on colorectal cancer screening adherenceJournal of Behavioral Medicine, 2015
- Genetic and Environmental Risk Assessment and Colorectal Cancer Screening in an Average-Risk PopulationAnnals of Internal Medicine, 2014
- Behavioral and psychosocial responses to genomic testing for colorectal cancer riskGenomics, 2013
- “Is it Really Worth it to Get Tested?”: Primary Care Patients’ Impressions of Predictive SNP Testing for Colon CancerJournal of Genetic Counseling, 2012
- Translational genomic research: protocol development and initial outcomes following SNP testing for colon cancer riskTranslational Behavioral Medicine, 2012
- Polygenic susceptibility to breast cancer and implications for preventionNature Genetics, 2002